Doxylamine Succinate And Pyridoxine Hydrochloride Tablet, Delayed Release
Product Images NDC 69452-206

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Doxylamine Succinate And Pyridoxine Hydrochloride (NDC 69452-206). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bionpharma Inc.,, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image001 (Image001)

Label for Doxylamine Succinate and Pyridoxine Hydrochloride delayed-release tablets 10 mg/10 mg. The label indicates 100 delayed-release tablets, distributed by Bionpharma Inc. It includes usage instructions, storage conditions, a warning not to crush, chew, or split the tablets, and pharmacist dispensing directions. The label also shows barcodes and a blank unvarnished area.*

FDA Label Image

Structure-1 (Structure001)

Chemical structure of doxylamine succinate, the active ingredient in the drug Doxylamine succinate and Pyridoxine hydrochloride. The diagram illustrates the molecular arrangement of atoms and bonds specific to doxylamine succinate.*

FDA Label Image

Structure-2 (Structure002)

Chemical structure of Pyridoxine hydrochloride, one of the active ingredients in Doxylamine succinate and Pyridoxine hydrochloride tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.